With 30 years global experience in life science and convergent technology innovation, we are experienced veterans in the sector, with substantial knowledge in fundraising, project management and health technology development.
With career long experiences in gene therapy, cell therapy and regenerative medicine, both as a researcher and a project manager, we also have significant expertise in fund raising (over €150 Mn raised), international project management (over 20 large scale international programmes and projects), and 5 years experience in diagnostics, patient care and management solutions, that can be applied to academic and industrial projects or projects that combine the two.
Leveraging our experience in health technology development including health technology assessments (HTA s) on a Global, Regional and country level we have also developed a novel valuation model that integrates pre-clinical, clinical, HTA and commercial potential allowing for optimised value making decisions throughout the whole life cycle of intervention development.
The impact of payer and reimbursement authorities evidence requirements on healthcare solution design: link
A novel valuation model for healthcare technologies development. Link
A cloud or a perfect storm? Assessing current status and future needs in Digital Health: link
Maximising outputs from early stage collaborations: link
A common apothecary cabinet – redesigning personalised medicine: link
2090..or 2020 – the future of regenerative medicine: link
The relevance of reimbursement rates and approved solution applicability on ROI: link
Market, needs and innovation opportunities in addiction to legal products. Link
A novel valuation model for medical intervention development: link
Innovation case study (Transvac) – designing an international early stage innovation ecosystem: link
Socioeconomic needs – putting health value before financial gain: link
Patient power – the importance of patients and patient associations in intervention design and validation: link